2025 Working Group Meeting Summary
How PDABs Impede Access
Turning Point for Valve Disease Treatment
What is HCM?
Delays in Diagnosing and Treating Hypertrophic Cardiomyopathy
Prescription Drug Affordability Boards and Personalized Care
Cardiac Myosin Inhibitors As A Treatment For HCM
Making Hypertension History for Veterans
Coverage Rules Limit Care for Heart Valve Patients
Optimizing Care for Hypertrophic Cardiomyopathy
